{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T23:58:18Z","timestamp":1790899098279,"version":"4.1.0"},"reference-count":82,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2026,6,4]],"date-time":"2026-06-04T00:00:00Z","timestamp":1780531200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,6,4]],"date-time":"2026-06-04T00:00:00Z","timestamp":1780531200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Arch Microbiol"],"published-print":{"date-parts":[[2026,8]]},"DOI":"10.1007\/s00203-026-04983-7","type":"journal-article","created":{"date-parts":[[2026,6,4]],"date-time":"2026-06-04T09:17:21Z","timestamp":1780564641000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Multifaceted DosR proteins of Mycobacterium tuberculosis: emerging roles for tuberculosis control"],"prefix":"10.1007","volume":"208","author":[{"given":"Manika","family":"Sharma","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Monika","family":"Sharma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sadhna","family":"Sharma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,4]]},"reference":[{"key":"4983_CR1","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1016\/j.coi.2018.04.004","volume":"53","author":"JM Achkar","year":"2018","unstructured":"Achkar JM, Prados-Rosales R (2018) Updates on antibody functions in Mycobacterium tuberculosis infection and their relevance for developing a vaccine against tuberculosis. Curr Opin Immunol 53:30\u201337. https:\/\/doi.org\/10.1016\/j.coi.2018.04.004","journal-title":"Curr Opin Immunol"},{"key":"4983_CR2","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3389\/fimmu.2017.00084","volume":"8","author":"N Ahmed","year":"2017","unstructured":"Ahmed N (2017) Mycobacterial Dormancy Systems and Host Responses in Tuberculosis. Front Immunol 8:1\u201319. https:\/\/doi.org\/10.3389\/fimmu.2017.00084","journal-title":"Front Immunol"},{"key":"4983_CR3","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1371\/journal.pone.0271126","volume":"17","author":"S Arif","year":"2022","unstructured":"Arif S, Akhter M, Khaliq A, Akhtar MW (2022) Fusion peptide constructs from antigens of M. tuberculosis producing high T-cell mediated immune response. PLoS ONE 17:1\u201315. https:\/\/doi.org\/10.1371\/journal.pone.0271126","journal-title":"PLoS ONE"},{"key":"4983_CR4","doi-asserted-by":"publisher","DOI":"10.1186\/s12879-025-11534-w","author":"M Ashayeripanah","year":"2025","unstructured":"Ashayeripanah M, Kazemi B, Saubi N, Joseph-Munne J, Eftekhar F (2025) Enhanced immunogenicity in mouse by recombinant BCG prime and protein boost based on latency antigen Rv1733c and\/or reactivation antigen RpfE. BMC Infect Dis. https:\/\/doi.org\/10.1186\/s12879-025-11534-w","journal-title":"BMC Infect Dis"},{"key":"4983_CR5","doi-asserted-by":"publisher","unstructured":"Ashraf S, Arif M, Saqib N, Sharif MZ, Khatak AA, Khan SN, Malik SA, Tahseen S, Khanum A (2014) Evaluation of diagnostic potential of Rv3803c and Rv2626c recombinant antigens in TB endemic country Pakistan. J Immunoass Immunochem 120\u2013129. https:\/\/doi.org\/10.1080\/15321819.2013.824897","DOI":"10.1080\/15321819.2013.824897"},{"key":"4983_CR6","doi-asserted-by":"publisher","first-page":"3063","DOI":"10.1016\/j.vaccine.2009.03.018","volume":"27","author":"SL Baldwin","year":"2009","unstructured":"Baldwin SL, Bertholet S, Kahn M, Zharkikh I, Ireton GC, Vedvick S, Reed SG, Coler RN (2009) Intradermal immunization improves protective efficacy of a novel TB vaccine candidate. Vaccine 27:3063\u20133071. https:\/\/doi.org\/10.1016\/j.vaccine.2009.03.018","journal-title":"Vaccine"},{"key":"4983_CR7","doi-asserted-by":"publisher","DOI":"10.1002\/cbdv.202402926","author":"M Battula","year":"2025","unstructured":"Battula M, Bhor S, Bhowmick S, Eldesoky GE, Chikhale RV (2025) Targeting Mycobacterial Dormancy Survival Regulator (DosR) with generative artificial intelligence and Omics methods. Chem Biodivers. https:\/\/doi.org\/10.1002\/cbdv.202402926","journal-title":"Chem Biodivers"},{"key":"4983_CR8","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2022.109238","author":"P Bhatt","year":"2022","unstructured":"Bhatt P, Sharma M, Sharma PP, Rathi B, Sharma S (2022) Mycobacterium tuberculosis dormancy regulon proteins Rv2627c and Rv2628 as Toll like receptor agonist and as potential adjuvant. Int Immunopharmacol. https:\/\/doi.org\/10.1016\/j.intimp.2022.109238","journal-title":"Int Immunopharmacol"},{"key":"4983_CR9","doi-asserted-by":"publisher","first-page":"4010","DOI":"10.1016\/j.vaccine.2009.04.033","volume":"27","author":"M Bivas-benita","year":"2009","unstructured":"Bivas-benita M, Young M, Bal SM, Van Meijgaarden KE, Franken KLMC, Friggen AH, Junginger HE, Borchard G, Klein MR, Ottenhoff THM (2009) Pulmonary delivery of DNA encoding Mycobacterium tuberculosis latency antigen Rv1733c associated to PLGA \u2013 PEI nanoparticles enhances T cell responses in a DNA prime \/ protein boost vaccination regimen in mice. Vaccine 27:4010\u20134017. https:\/\/doi.org\/10.1016\/j.vaccine.2009.04.033","journal-title":"Vaccine"},{"key":"4983_CR10","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1371\/journal.pone.0181714","volume":"12","author":"J Castro-Garza","year":"2017","unstructured":"Castro-Garza J, Garc\u00eda-Jacobo P, Rivera-Morales LG, Quinn FD, Barber J, Karls R, Haas D, Helms S, Gupta T, Blumberg H, Tapia J, Luna-Cruz I, Rendon A, Vargas-Villarreal J, Vera-Cabrera L, Rodr\u00edguez-Padilla C (2017) Detection of anti-HspX antibodies and HspX protein in patient sera for the identification of recent latent infection by Mycobacterium tuberculosis. PLoS One 12:1\u201313. https:\/\/doi.org\/10.1371\/journal.pone.0181714","journal-title":"PLoS One"},{"key":"4983_CR12","doi-asserted-by":"publisher","first-page":"2540","DOI":"10.1021\/acsinfecdis.2c00414","volume":"8","author":"P Chauhan","year":"2022","unstructured":"Chauhan P, Datta I, Dhiman A, Shankar U, Kumar A, Vashist A, Sharma TK, Tyagi JS (2022) DNA aptamer targets Mycobacterium tuberculosis DevR\/DosR response regulator function by inhibiting its dimerization and DNA binding activity. ACS Infect Dis 8:2540\u20132551. https:\/\/doi.org\/10.1021\/acsinfecdis.2c00414","journal-title":"ACS Infect Dis"},{"key":"4983_CR11","doi-asserted-by":"publisher","first-page":"7400","DOI":"10.1093\/nar\/gkr375","volume":"39","author":"S Chauhan","year":"2011","unstructured":"Chauhan S, Sharma D, Singh A, Surolia A, Tyagi JS (2011) Comprehensive insights into Mycobacterium tuberculosis DevR ( DosR ) regulon activation switch. Nucleic Acids Res 39:7400\u20137414. https:\/\/doi.org\/10.1093\/nar\/gkr375","journal-title":"Nucleic Acids Res"},{"key":"4983_CR13","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2334-12-10","author":"NN Chegou","year":"2012","unstructured":"Chegou NN, Black GF, Loxton AG, Stanley K, Essone PN, Klein MR, Parida SK, Kaufmann SHE, Doherty TM, Friggen AH, Franken KL, Ottenhoff TH, Walzl G (2012) Potential of novel Mycobacterium tuberculosis infection phase-dependent antigens in the diagnosis of TB disease in a high burden setting. BMC Infect Dis. https:\/\/doi.org\/10.1186\/1471-2334-12-10","journal-title":"BMC Infect Dis"},{"key":"4983_CR14","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1371\/journal.pone.0038501","volume":"7","author":"NN Chegou","year":"2012","unstructured":"Chegou NN, Essone PN, Loxton AG, Stanley K, Black GF, van der Spuy GD, van Helden PD, Franken KL, Parida SK, Klein MR, Kaufmann SHE, Ottenhoff THM, Walzl G (2012) Potential of host markers produced by infection phase-dependent antigen-stimulated cells for the diagnosis of tuberculosis in a highly endemic area. PLoS One 7:1\u201310. https:\/\/doi.org\/10.1371\/journal.pone.0038501","journal-title":"PLoS One"},{"key":"4983_CR15","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2024.112811","volume":"139","author":"Z Chen","year":"2024","unstructured":"Chen Z, Zhang Y, Wu J, Xu J, Hu Z, Fan XY (2024) A multistage protein subunit vaccine as BCG-booster confers protection against Mycobacterium tuberculosis infection in murine models. Int Immunopharmacol 139:112811. https:\/\/doi.org\/10.1016\/j.intimp.2024.112811","journal-title":"Int Immunopharmacol"},{"key":"4983_CR16","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3390\/arm93030019","volume":"93","author":"M Chouhan","year":"2025","unstructured":"Chouhan M, Kumar M, Dwivedi VD, Kashyap VK, Singh HN, Kumar S (2025) Harnessing natural product compounds to target dormancy survival regulator (DosR) in latent tuberculosis infection (LTBI): an in silico strategy against dormancy. Adv Respir Med 93:1\u201318. https:\/\/doi.org\/10.3390\/arm93030019","journal-title":"Adv Respir Med"},{"key":"4983_CR17","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1371\/journal.pone.0038709","volume":"7","author":"I Datin","year":"2012","unstructured":"Datin I, Kumar A, Majid M, Kunisch R, Rani PS, Qureshi IA, Lewin A, Hasnain SE, Ahmed N (2012) Mycobacterium tuberculosis DosR Regulon Gene Rv0079 Encodes a Putative, \u2018Dormancy Associated Translation. PLoS Med 7:1\u20137. https:\/\/doi.org\/10.1371\/journal.pone.0038709","journal-title":"PLoS Med"},{"key":"4983_CR18","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/j.tube.2018.07.004","volume":"112","author":"A Dhiman","year":"2018","unstructured":"Dhiman A, Haldar S, Mishra SK, Sharma N, Bansal A, Ahmad Y, Kumar A, Sharma TK, Tyagi JS (2018) Generation and application of DNA aptamers against HspX for accurate diagnosis of tuberculous meningitis. Tuberculosis 112:27\u201336. https:\/\/doi.org\/10.1016\/j.tube.2018.07.004","journal-title":"Tuberculosis"},{"key":"4983_CR19","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2017.00712","author":"SN Doddam","year":"2017","unstructured":"Doddam SN, Peddireddy V, Ahmed N (2017) Mycobacterium tuberculosis DosR regulon gene Rv2004c encodes a novel antigen with pro-inflammatory functions and potential diagnostic application for detection of latent tuberculosis. Front Immunol. https:\/\/doi.org\/10.3389\/fimmu.2017.00712","journal-title":"Front Immunol"},{"key":"4983_CR20","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3390\/ijms222413317","volume":"22","author":"A Egorova","year":"2021","unstructured":"Egorova A, Salina EG (2021) Targeting Non-Replicating Mycobacterium tuberculosis and Latent Infection: Alternatives and Perspectives (Mini-Review). Int J Mol Sci 22:1\u201315","journal-title":"Int J Mol Sci"},{"key":"4983_CR21","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1016\/j.tube.2010.04.001","volume":"90","author":"M Flores Valdez","year":"2010","unstructured":"Flores Valdez M, Schoolnik G (2010) DosR-regulon genes induction in Mycobacterium bovis BCG under aerobic conditions. Tuberculosis 90:197\u2013200. https:\/\/doi.org\/10.1016\/j.tube.2010.04.001","journal-title":"Tuberculosis"},{"key":"4983_CR22","doi-asserted-by":"publisher","DOI":"10.1016\/j.cellimm.2019.103947","volume":"344","author":"X Gao","year":"2019","unstructured":"Gao X, Wu C, He W, Wang X, Li Y, Wang Y, Jia Y, Yuan R, Li H, Zhang B (2019) DosR antigen Rv1737c induces activation of macrophages dependent on the TLR2 pathway. Cell Immunol 344:103947. https:\/\/doi.org\/10.1016\/j.cellimm.2019.103947","journal-title":"Cell Immunol"},{"key":"4983_CR23","doi-asserted-by":"publisher","first-page":"6324","DOI":"10.1021\/jm900358q","volume":"52","author":"RK Gupta","year":"2009","unstructured":"Gupta RK, Thakur TS, Desiraju GR, Tyagi JS (2009) Structure-based design of DevR inhibitor active against nonreplicating Mycobacterium tuberculosis. J Med Chem 52:6324\u20136334. https:\/\/doi.org\/10.1021\/jm900358q","journal-title":"J Med Chem"},{"key":"4983_CR25","doi-asserted-by":"publisher","first-page":"2427","DOI":"10.1007\/s10096-021-04246-x","volume":"40","author":"C Huang","year":"2021","unstructured":"Huang C, Pan L, Shen X, Tian H, Guo L, Zhang Z, Liu X (2021) Hsp16.3 of mycobacterium tuberculosis in exosomes as a biomarker of tuberculosis. Eur J Clin Microbiol Infect Dis 40:2427\u20132430. https:\/\/doi.org\/10.1007\/s10096-021-04246-x","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"4983_CR24","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2025.1624923","author":"Z Hu","year":"2025","unstructured":"Hu Z, Guo S, Chen W (2025) Therapeutic vaccination with the Ag85B-Rv2660c-MPT70 fusion protein enhances Mycobacterium tuberculosis H37Ra clearance in post-exposure mice. Front Immunol. https:\/\/doi.org\/10.3389\/fimmu.2025.1624923","journal-title":"Front Immunol"},{"key":"4983_CR26","doi-asserted-by":"publisher","DOI":"10.1186\/s40794-024-00235-y","author":"E Isaei","year":"2024","unstructured":"Isaei E, Sobhanipoor MH, Rahimlou M, Firouzeh N (2024) The application of aptamer in tuberculosis diagnosis: A systematic review. Trop Dis Travel Med Vaccines. https:\/\/doi.org\/10.1186\/s40794-024-00235-y","journal-title":"Trop Dis Travel Med Vaccines"},{"key":"4983_CR27","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1155\/2013\/309816","volume":"35","author":"RK Jain","year":"2013","unstructured":"Jain RK, Nayak AR, Husain AA, Panchbhai MS, Chandak N, Purohit HJ, Taori GM, Daginawala HF, Kashyap RS (2013) Mycobacterial dormancy regulon protein Rv2623 as a Novel biomarker for the diagnosis of latent and active tuberculous meningitis. Dis Markers 35:311\u2013316. https:\/\/doi.org\/10.1155\/2013\/309816","journal-title":"Dis Markers"},{"key":"4983_CR28","doi-asserted-by":"publisher","first-page":"425","DOI":"10.2174\/1573409919666230201100543","volume":"19","author":"B Jee","year":"2023","unstructured":"Jee B, Sharma PP, Goel VK, Kumar S, Singh Y, Rathi B (2023) Natural Metabolite Ursolic Acid as an Inhibitor of Dormancy Regulator DosR of Mycobacterium tuberculosis: Evidence from Molecular Docking, Molecular Dynamics Simulation and Free Energy Analysis. Curr Comput Aided Drug Des 19:425\u2013437. https:\/\/doi.org\/10.2174\/1573409919666230201100543","journal-title":"Curr Comput Aided Drug Des"},{"key":"4983_CR29","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/j.imlet.2022.01.001","volume":"242","author":"KJ Kanaparthi","year":"2022","unstructured":"Kanaparthi KJ, Afroz S, Minhas G, Moitra A, Khan RA, Medikonda J, Naz S, Cholleti SN, Banerjee S, Khan N (2022) Immunogenic profiling of Mycobacterium tuberculosis DosR protein Rv0569 reveals its ability to switch on Th1 based immunity. Immunol Lett 242:27\u201336. https:\/\/doi.org\/10.1016\/j.imlet.2022.01.001","journal-title":"Immunol Lett"},{"key":"4983_CR30","doi-asserted-by":"publisher","first-page":"4130","DOI":"10.1016\/j.vaccine.2015.06.051","volume":"33","author":"A Kany","year":"2015","unstructured":"Kany A, Luabeya K, Kagina BMN, Tameris MD, Geldenhuys H, Hoff ST, Shi Z, Kromann I, Hatherill M, Mahomed H, Hanekom WA, Andersen P, Scriba TJ, H.- Trial, S. Group, T.H.- Trial, S. Group, Schoeman E, Krohn C, Day CL, Africa H, Makhethe L, Smit E, Brown Y, Suliman S, Hughes EJ, Bang P, Snowden MA, Mcclain B, Hussey GD (2015) First-in-human trial of the post-exposure tuberculosis vaccine H56\u202f: IC31 in Mycobacterium tuberculosis infected and non-infected healthy adults. Vaccine 33:4130\u20134140. https:\/\/doi.org\/10.1016\/j.vaccine.2015.06.051","journal-title":"Vaccine"},{"key":"4983_CR31","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s00284-024-03655-3","volume":"81","author":"M Karbalaei","year":"2024","unstructured":"Karbalaei M, Mosavat A, Soleimanpour S, Farsiani H, Ghazvini K (2024) Production and Evaluation of Ag85B: HspX : hFc\u03b31 Immunogenicity as an Fc Fusion Recombinant Multi \u2013 Stage Vaccine Candidate Against Mycobacterium tuberculosis. Curr Microbiol 81:1\u201313. https:\/\/doi.org\/10.1007\/s00284-024-03655-3","journal-title":"Curr Microbiol"},{"key":"4983_CR32","doi-asserted-by":"publisher","first-page":"1","DOI":"10.15252\/emmm.202012497","volume":"12","author":"SY Kim","year":"2020","unstructured":"Kim SY, Kim D, Kim S, Lee D, Mun S, Cho E, Son W, Jang K, Yang C (2020) Mycobacterium tuberculosis Rv2626c-derived peptide as a therapeutic agent for sepsis. EMBO Mol Med 12:1\u201317. https:\/\/doi.org\/10.15252\/emmm.202012497","journal-title":"EMBO Mol Med"},{"key":"4983_CR33","doi-asserted-by":"publisher","unstructured":"Kong H, Dong C, Xiong S, Kong H, Dong C, Xiong S (2014) A novel vaccine p846 encoding Rv3615c, Mtb10.4 and Rv2660c elicits robust immune response and alleviates lung injury induced by Mycobacterium A novel vaccine p846 encoding Rv3615c, Mtb10. 4, and Rv2660c elicits robust immune response and alleviates lun, Hum. Vaccines Immunother 5515. https:\/\/doi.org\/10.4161\/hv.27121","DOI":"10.4161\/hv.27121"},{"key":"4983_CR34","doi-asserted-by":"publisher","DOI":"10.3389\/ftubr.2024.1438406","author":"I Kudryavtsev","year":"2024","unstructured":"Kudryavtsev I, Starshinova A, Rubinstein A, Kulpina A, Ling H, Zhuang M, Kudlay D (2024) The role of the immune response in developing tuberculosis infection: from latent infection to active tuberculosis. Front Tuberc. https:\/\/doi.org\/10.3389\/ftubr.2024.1438406","journal-title":"Front Tuberc"},{"key":"4983_CR35","doi-asserted-by":"publisher","DOI":"10.1016\/j.tube.2022.102206","volume":"134","author":"P Kumari","year":"2022","unstructured":"Kumari P, Dhiman A, Lavania S, Sharma P, Rath D, Anthwal D, Gupta RK, Kochar A, Sharma N, Gadpayle AK, Taneja RS, Sharma L, Haldar S, Sharma TK, Tyagi JS (2022) Assessment of DNA aptamers targeting GlcB and HspX antigens for application in the diagnosis of abdominal tuberculosis. Tuberculosis 134:102206. https:\/\/doi.org\/10.1016\/j.tube.2022.102206","journal-title":"Tuberculosis"},{"key":"4983_CR36","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41541-024-00847-7","volume":"9","author":"KW Kwon","year":"2024","unstructured":"Kwon KW, Choi HG, Kim KS, Park SA, Kim HJ, Shin SJ (2024) BCG-booster vaccination with HSP90-ESAT-6-HspX-RipA multivalent subunit vaccine confers durable protection against hypervirulent Mtb in mice. Npj Vaccines 9:1\u201312. https:\/\/doi.org\/10.1038\/s41541-024-00847-7","journal-title":"Npj Vaccines"},{"key":"4983_CR37","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/srep44151","volume":"7","author":"KW Kwon","year":"2017","unstructured":"Kwon KW, Kim WS, Kim H, Han SJ, Hahn MY, Lee JS, Nam KT, Cho SN, Shin SJ (2017) Novel vaccine potential of Rv3131, a DosR regulon-encoded putative nitroreductase, against hyper-virulent Mycobacterium tuberculosis strain K. Sci Rep 7:1\u201313. https:\/\/doi.org\/10.1038\/srep44151","journal-title":"Sci Rep"},{"key":"4983_CR38","doi-asserted-by":"publisher","first-page":"1662","DOI":"10.1128\/JB.00926-09","volume":"192","author":"RL Leistikow","year":"2010","unstructured":"Leistikow RL, Morton RA, Bartek IL, Frimpong I, Wagner K, Voskuil MI (2010) The Mycobacterium tuberculosis DosR regulon assists in metabolic homeostasis and enables rapid recovery from nonrespiring dormancy. J Bacteriol 192:1662\u20131670. https:\/\/doi.org\/10.1128\/JB.00926-09","journal-title":"J Bacteriol"},{"key":"4983_CR40","doi-asserted-by":"publisher","first-page":"3523","DOI":"10.1128\/IAI.01999-06","volume":"75","author":"MY Lin","year":"2007","unstructured":"Lin MY, Geluk A, Smith SG, Stewart AL, Friggen AH, Franken KLMC, Verduyn MJC, Van Meijgaarden KE, Voskuil MI, Dockrell HM, Huygen K, Ottenhoff THM, Al LINET, Mmun INI (2007) Lack of immune responses to Mycobacterium tuberculosis DosR regulon proteins following Mycobacterium bovis BCG vaccination. Infect Immun 75:3523\u20133530. https:\/\/doi.org\/10.1128\/IAI.01999-06","journal-title":"Infect Immun"},{"key":"4983_CR41","doi-asserted-by":"publisher","first-page":"15","DOI":"10.4049\/jimmunol.0903856","volume":"185","author":"PL Lin","year":"2010","unstructured":"Lin PL, Flynn JL (2010) Understanding Latent Tuberculosis: A Moving Target. J Immunol 185:15\u201322. https:\/\/doi.org\/10.4049\/jimmunol.0903856","journal-title":"J Immunol"},{"key":"4983_CR39","doi-asserted-by":"publisher","first-page":"568","DOI":"10.1111\/j.1365-3083.2011.02531.x","volume":"73","author":"Q Li","year":"2011","unstructured":"Li Q, Yu H, Zhang Y, Wang B, Jiang W, Da Z, Xian Q, Wang Y, Liu X, Zhu B (2011) Immunogenicity and Protective Efficacy of a Fusion Protein Vaccine Consisting of Antigen Ag85B and HspX against Mycobacterium tuberculosis Infection in Mice. Scand J Immunol 73:568\u2013576. https:\/\/doi.org\/10.1111\/j.1365-3083.2011.02531.x","journal-title":"Scand J Immunol"},{"key":"4983_CR42","doi-asserted-by":"publisher","first-page":"5825","DOI":"10.3390\/cimb46060348","volume":"46","author":"Y Liu","year":"2024","unstructured":"Liu Y, Li H, Dai D, He J, Liang Z (2024) Gene regulatory mechanism of Mycobacterium tuberculosis during dormancy. Curr Issues Mol Biol 46:5825\u20135844. https:\/\/doi.org\/10.3390\/cimb46060348","journal-title":"Curr Issues Mol Biol"},{"key":"4983_CR43","first-page":"156","volume":"7","author":"D Mansury","year":"2019","unstructured":"Mansury D, Ghazvini K, Jamehdar SA, Badiee A, Tafaghodi M, Nikpoor AR, Amini Y, Jaafari MR (2019) Increasing cellular immune response in liposomal formulations of DOTAP encapsulated by fusion protein Hspx, PPE44, And Esxv, as a potential tuberculosis vaccine candidate. Rep Biochem Mol Biol 7:156\u2013166","journal-title":"Rep Biochem Mol Biol"},{"key":"4983_CR44","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2018.02476","author":"NR Meier","year":"2018","unstructured":"Meier NR, Jacobsen M, Ottenhoff THM, Ritz N (2018) A systematic review on novel Mycobacterium tuberculosisantigens and their discriminatory potential for the diagnosis of latent and active tuberculosis. Front Immunol. https:\/\/doi.org\/10.3389\/fimmu.2018.02476","journal-title":"Front Immunol"},{"key":"4983_CR45","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1183\/20734735.0079-2021","volume":"17","author":"GB Migliori","year":"2021","unstructured":"Migliori GB, Ong CWM, Centis R, Goletti D, Petrone L, Ambrosio LD (2021) The definition of tuberculosis infection based on the spectrum of tuberculosis disease. Breathe 17:1\u201312. https:\/\/doi.org\/10.1183\/20734735.0079-2021","journal-title":"Breathe"},{"key":"4983_CR46","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1080\/07391102.2009.10507316","volume":"27","author":"S Mishra","year":"2012","unstructured":"Mishra S (2012) Function prediction of Rv0079, a hypothetical Mycobacterium tuberculosis DosR regulon protein. J Biomol Struct Dyn 27:283\u2013291. https:\/\/doi.org\/10.1080\/07391102.2009.10507316","journal-title":"J Biomol Struct Dyn"},{"key":"4983_CR47","doi-asserted-by":"publisher","DOI":"10.22038\/ijbms.2020.38521.9171","author":"B Moradi","year":"2020","unstructured":"Moradi B, Sankian M, Amini Y, Gholoobi A, Meshkat Z (2020) A new DNA vaccine expressing HspX-PPE44-EsxV fusion antigens of Mycobacterium tuberculosis induced strong immune responses. Iran J Basic Med Sci. https:\/\/doi.org\/10.22038\/ijbms.2020.38521.9171","journal-title":"Iran J Basic Med Sci"},{"key":"4983_CR48","doi-asserted-by":"publisher","first-page":"9451","DOI":"10.1016\/j.vaccine.2011.10.032","volume":"29","author":"H Niu","year":"2011","unstructured":"Niu H, Hu L, Li Q, Da Z, Wang B, Tang K, Xin Q, Yu H, Zhang Y, Wang Y, Ma X, Zhu B (2011) Construction and evaluation of a multistage Mycobacterium tuberculosis subunit vaccine candidate Mtb10.4-HspX. Vaccine 29:9451\u20139458. https:\/\/doi.org\/10.1016\/j.vaccine.2011.10.032","journal-title":"Vaccine"},{"key":"4983_CR49","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1371\/journal.pone.0130641","volume":"10","author":"H Niu","year":"2015","unstructured":"Niu H, Peng J, Bai C, Liu X, Hu L, Luo Y, Wang B, Zhang Y, Chen J, Yu H, Xian Q, Zhu B (2015) Multi-stage tuberculosis subunit vaccine candidate LT69 provides high protection against Mycobacterium tuberculosis infection in mice. PLoS ONE 10:1\u201311. https:\/\/doi.org\/10.1371\/journal.pone.0130641","journal-title":"PLoS ONE"},{"key":"4983_CR50","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1016\/j.ijmyco.2015.10.005","volume":"5","author":"K Pandey","year":"2016","unstructured":"Pandey K, Sharma M, Saarav I, Singh S, Dutta P, Bhardwaj A, Sharma S (2016) Analysis of the DosR regulon genes to select cytotoxic T lymphocyte epitope specific vaccine candidates using a reverse vaccinology approach. Int J Mycobacteriology 5:34\u201343. https:\/\/doi.org\/10.1016\/j.ijmyco.2015.10.005","journal-title":"Int J Mycobacteriology"},{"key":"4983_CR51","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1016\/j.micpath.2018.11.029","volume":"126","author":"K Pandey","year":"2019","unstructured":"Pandey K, Singh S, Bhatt P, Medha M, Sharma A, Chaudhry S, Sharma (2019) DosR proteins of Mycobacterium tuberculosis upregulate effector T cells and down regulate T regulatory cells in TB patients and their healthy contacts. Microb Pathog 126:399\u2013406. https:\/\/doi.org\/10.1016\/j.micpath.2018.11.029","journal-title":"Microb Pathog"},{"key":"4983_CR53","doi-asserted-by":"publisher","first-page":"833","DOI":"10.1046\/j.1365-2958.2003.03474.x","volume":"48","author":"H Park","year":"2007","unstructured":"Park H, Guinn KM, Harrell MI, Liao R, Voskuil MI, Schoolnik GK, Sherman DR (2007) Rv3133c\/dosR is a transcription factor that mediates the hypoxic response of Mycobacterium tuberculosis. Mol Microbiol 48:833\u2013843. https:\/\/doi.org\/10.1046\/j.1365-2958.2003.03474.x","journal-title":"Mol Microbiol"},{"key":"4983_CR54","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1016\/S0966-842X(98)01216-5","volume":"6","author":"NM Parrish","year":"1998","unstructured":"Parrish NM, Dick JD, Bishai WR (1998) Mechanisms of latency in Mycobacterium tuberculosis. Trends Microbiol 6:107\u2013112. https:\/\/doi.org\/10.1016\/S0966-842X(98)01216-5","journal-title":"Trends Microbiol"},{"key":"4983_CR55","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/srep24535","volume":"6","author":"V Peddireddy","year":"2016","unstructured":"Peddireddy V, Doddam SN, Qureshi IA, Yerra P, Ahmed N (2016) A putative nitroreductase from the DosR regulon of Mycobacterium tuberculosis induces pro-inflammatory cytokine expression via TLR2 signaling pathway. Sci Rep 6:1\u20139. https:\/\/doi.org\/10.1038\/srep24535","journal-title":"Sci Rep"},{"key":"4983_CR56","doi-asserted-by":"publisher","first-page":"1110","DOI":"10.1021\/acsinfecdis.9b00502","volume":"6","author":"EC Pel\u00e1ez","year":"2020","unstructured":"Pel\u00e1ez EC, Estevez MC, Mongui A, Men\u00e9ndez MC, Toro C, Herrera-Sandoval OL, Robledo J, Garc\u00eda MJ, Del Portillo P, Lechuga LM (2020) Detection and quantification of HspX antigen in sputum samples using plasmonic biosensing: toward a real point-of-care (POC) for tuberculosis diagnosis. ACS Infect Dis 6:1110\u20131120. https:\/\/doi.org\/10.1021\/acsinfecdis.9b00502","journal-title":"ACS Infect Dis"},{"key":"4983_CR57","doi-asserted-by":"publisher","first-page":"12523","DOI":"10.1021\/bi8012356","volume":"47","author":"LM Podust","year":"2008","unstructured":"Podust LM, Ioanoviciu A, Ortiz De Montellano PR (2008) 2.3 A X-ray structure of the heme-bound GAF domain of sensory histidine kinase DosT of Mycobacterium tuberculosis. Biochemistry 47:12523\u201312531. https:\/\/doi.org\/10.1021\/bi8012356","journal-title":"Biochemistry"},{"key":"4983_CR58","doi-asserted-by":"publisher","first-page":"5284","DOI":"10.1080\/21645515.2021.2007711","volume":"17","author":"M Qu","year":"2021","unstructured":"Qu M, Zhou X, Li H (2021) BCG vaccination strategies against tuberculosis: updates and perspectives. Hum Vaccin Immunother 17:5284\u20135295. https:\/\/doi.org\/10.1080\/21645515.2021.2007711","journal-title":"Hum Vaccin Immunother"},{"key":"4983_CR59","doi-asserted-by":"publisher","first-page":"8740","DOI":"10.1016\/j.vaccine.2011.07.144","volume":"29","author":"ST Reece","year":"2011","unstructured":"Reece ST, Nasser-Eddine A, Dietrich J, Stein M, Zedler U, Schommer-Leitner S, Ottenhoff THM, Andersen P, Kaufmann SHE (2011) Improved long-term protection against Mycobacterium tuberculosis Beijing\/W in mice after intra-dermal inoculation of recombinant BCG expressing latency associated antigens. Vaccine 29:8740\u20138744. https:\/\/doi.org\/10.1016\/j.vaccine.2011.07.144","journal-title":"Vaccine"},{"key":"4983_CR60","doi-asserted-by":"publisher","first-page":"23082","DOI":"10.1074\/jbc.M401230200","volume":"279","author":"DM Roberts","year":"2004","unstructured":"Roberts DM, Liao RP, Wisedchaisri G, Hol WGJ, Sherman DR (2004) Two sensor kinases contribute to the hypoxic response of Mycobacterium tuberculosis. J Biol Chem 279:23082\u201323087. https:\/\/doi.org\/10.1074\/jbc.M401230200","journal-title":"J Biol Chem"},{"key":"4983_CR61","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-023-36789-2","author":"ZK Sagawa","year":"2023","unstructured":"Sagawa ZK, Goman C, Frevol A, Blazevic A, Tennant J, Fisher B, Day T, Jackson S, Lemiale F, Toussaint L, Kalisz I, Jiang J, Ondrejcek L, Mohamath R, Vergara J, Lew A, Beckmann AM, Casper C, Hoft DF, Fox CB (2023) Safety and immunogenicity of a thermo- stable ID93\u2009+\u2009GLA-SE tuberculosis vaccine candidate in healthy adults. Nat Commun. https:\/\/doi.org\/10.1038\/s41467-023-36789-2","journal-title":"Nat Commun"},{"key":"4983_CR62","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1016\/j.gene.2012.06.033","volume":"506","author":"S Selvaraj","year":"2012","unstructured":"Selvaraj S, Sambandam V, Sardar D, Anishetty S (2012) In silico analysis of DosR regulon proteins of Mycobacterium tuberculosis. Gene 506:233\u2013241. https:\/\/doi.org\/10.1016\/j.gene.2012.06.033","journal-title":"Gene"},{"key":"4983_CR63","doi-asserted-by":"publisher","DOI":"10.1016\/j.redox.2022.102316","volume":"52","author":"RR Sevalkar","year":"2022","unstructured":"Sevalkar RR, Glasgow JN, Pettinati M, Marti MA, Reddy VP, Basu S, Alipour E, Kim-Shapiro DB, Estrin DA, Lancaster JR, Steyn AJC (2022) Mycobacterium tuberculosis DosS binds H2S through its Fe3+ heme iron to regulate the DosR dormancy regulon. Redox Biol 52:102316. https:\/\/doi.org\/10.1016\/j.redox.2022.102316","journal-title":"Redox Biol"},{"key":"4983_CR64","doi-asserted-by":"publisher","first-page":"3242","DOI":"10.1080\/07391102.2020.1846620","volume":"40","author":"VG Shanmuga Priya","year":"2022","unstructured":"Shanmuga Priya VG, Bhandare V, Muddapur UM, Swaminathan P, Fandilolu PM, Sonawane KD (2022) Molecular modeling approach to identify inhibitors of Rv2004c (rough morphology and virulent strain gene), a DosR (dormancy survival regulator) regulon protein from Mycobacterium tuberculosis. J Biomol Struct Dyn 40:3242\u20133257. https:\/\/doi.org\/10.1080\/07391102.2020.1846620","journal-title":"J Biomol Struct Dyn"},{"key":"4983_CR65","doi-asserted-by":"publisher","DOI":"10.1016\/j.molstruc.2021.132278","volume":"1254","author":"D Sharma","year":"2022","unstructured":"Sharma D, Sharma S, Sinha N, Jain N, Kumar A, Sarkar A, Tyagi JS, Gupta RK (2022) Novel benzoic thiazolidin-4-one derivatives targeting DevR\/DosR dormancy regulator of Mycobacterium tuberculosis. J Mol Struct 1254:132278. https:\/\/doi.org\/10.1016\/j.molstruc.2021.132278","journal-title":"J Mol Struct"},{"key":"4983_CR66","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3389\/fcimb.2023.1111997","volume":"13","author":"S Sharma","year":"2023","unstructured":"Sharma S, Chikhale R, Shinde N, Khan AM, Gupta VK (2023) Targeting dormant phenotype acquired mycobacteria using natural products by exploring its important targets: In vitro and in silico studies. Front Cell Infect Microbiol 13:1\u201314. https:\/\/doi.org\/10.3389\/fcimb.2023.1111997","journal-title":"Front Cell Infect Microbiol"},{"key":"4983_CR67","doi-asserted-by":"publisher","first-page":"272","DOI":"10.1021\/acsinfecdis.9b00329","volume":"6","author":"S Shi","year":"2020","unstructured":"Shi S, Hsueh P, Yang P, Chou C (2020) Use of DosR dormancy antigens from Mycobacterium tuberculosis for serodiagnosis of active and latent tuberculosis. ACS Infect Dis 6:272\u2013280. https:\/\/doi.org\/10.1021\/acsinfecdis.9b00329","journal-title":"ACS Infect Dis"},{"key":"4983_CR69","doi-asserted-by":"publisher","DOI":"10.1016\/j.meegid.2019.103930","author":"M Singh","year":"2019","unstructured":"Singh M, Bhatt P, Sharma M, Varma-Basil M, Chaudhry A, Sharma S (2019) Immunogenicity of late stage specific peptide antigens of Mycobacterium tuberculosis. Infect Genet Evol. https:\/\/doi.org\/10.1016\/j.meegid.2019.103930","journal-title":"Infect Genet Evol"},{"key":"4983_CR68","doi-asserted-by":"publisher","first-page":"712","DOI":"10.1016\/j.vaccine.2013.11.065","volume":"32","author":"S Singh","year":"2014","unstructured":"Singh S, Saraav I, Sharma S (2014) Immunogenic potential of latency associated antigens against Mycobacterium tuberculosis. Vaccine 32:712\u2013716. https:\/\/doi.org\/10.1016\/j.vaccine.2013.11.065","journal-title":"Vaccine"},{"key":"4983_CR70","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1016\/j.cimid.2018.11.016","volume":"62","author":"S Singh","year":"2019","unstructured":"Singh S, Sharma M, Chaudhry A, Sharma S (2019) Rv2626c and Rv2032 activate TH1 response and downregulate regulatory T cells in peripheral blood mononuclear cells of tuberculosis patients. Comp Immunol Microbiol Infect Dis 62:46\u201353. https:\/\/doi.org\/10.1016\/j.cimid.2018.11.016","journal-title":"Comp Immunol Microbiol Infect Dis"},{"key":"4983_CR71","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3389\/fmicb.2017.02266","volume":"8","author":"H Su","year":"2017","unstructured":"Su H, Zhu S, Zhu L, Kong C, Huang Q, Zhang Z, Wang H, Xu Y (2017) Mycobacterium tuberculosis latent antigen Rv2029c from the multistage DNA vaccine A39 drives TH1 responses via TLR-mediated macrophage activation. Front Microbiol 8:1\u201318. https:\/\/doi.org\/10.3389\/fmicb.2017.02266","journal-title":"Front Microbiol"},{"key":"4983_CR72","doi-asserted-by":"publisher","DOI":"10.1016\/j.gene.2025.149868","volume":"977","author":"K Sundaram","year":"2026","unstructured":"Sundaram K, Rathinam S (2026) Functional analysis of two component signaling system in Mycobacterium tuberculosis. Gene 977:149868. https:\/\/doi.org\/10.1016\/j.gene.2025.149868","journal-title":"Gene"},{"key":"4983_CR73","unstructured":"Wei R, Chen H, Li Y, Zhang X, Yu W, Jing C, Liu S, Qin L, Lyu M (2025) A novel nanoparticle vaccine displaying multistage tuberculosis antigens confers protection in mice infected with H37Rv"},{"key":"4983_CR74","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3389\/fimmu.2022.1025931","volume":"13","author":"S Weng","year":"2022","unstructured":"Weng S, Zhang J, Ma H, Zhou J, Jia L, Wan Y, Cui P, Ruan Q, Shao L, Wu J, Wang H, Zhang W, Xu Y (2022) B21 DNA vaccine expressing ag85b, rv2029c, and rv1738 confers a robust therapeutic effect against latent Mycobacterium tuberculosis infection. Front Immunol 13:1\u201313. https:\/\/doi.org\/10.3389\/fimmu.2022.1025931","journal-title":"Front Immunol"},{"key":"4983_CR76","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1016\/j.jmb.2008.02.029","volume":"23","author":"G Wisedchaisri","year":"2008","unstructured":"Wisedchaisri G, Meiting W, David SR, Hol WGJ (2008) Crystal Structures of the Response Regulator DosR from Mycobacterium tuberculosis Suggest a Helix Rearrangement Mechanism for Phosphorylation Activation. J Mol 23:227\u2013242. https:\/\/www.ncbi.nlm.nih.gov\/pmc\/articles\/PMC3624763\/pdf\/nihms412728.pdf","journal-title":"J Mol"},{"key":"4983_CR75","doi-asserted-by":"publisher","first-page":"630","DOI":"10.1016\/j.jmb.2005.09.048","volume":"354","author":"G Wisedchaisri","year":"2005","unstructured":"Wisedchaisri G, Wu M, Rice AE, Roberts DM, Sherman DR, Hol WGJ (2005) Structures of Mycobacterium tuberculosis DosR and DosR-DNA complex involved in gene activation during adaptation to hypoxic latency. J Mol Biol 354:630\u2013641. https:\/\/doi.org\/10.1016\/j.jmb.2005.09.048","journal-title":"J Mol Biol"},{"key":"4983_CR77","unstructured":"World Health Organisation (2025) Global Tuberculosis Report ISBN: 978-92-4-011692-4"},{"key":"4983_CR78","doi-asserted-by":"publisher","first-page":"2490","DOI":"10.1016\/j.vaccine.2011.06.029","volume":"30","author":"W Yuan","year":"2012","unstructured":"Yuan W, Dong N, Zhang L, Liu J, Lin S, Xiang Z, Qiao H, Tong W (2012) Immunogenicity and protective efficacy of a tuberculosis DNA vaccine expressing a fusion protein of Ag85B-Esat6-HspX in mice. Vaccine 30:2490\u20132497. https:\/\/doi.org\/10.1016\/j.vaccine.2011.06.029","journal-title":"Vaccine"},{"key":"4983_CR79","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2025.1492268","author":"J Yun","year":"2025","unstructured":"Yun J, Shin E, Lee Y, Lee J, Lee H, Kim J, Shin SJ, Ha S, Lee S, Kim D, Yoo J (2025) Immunogenicity and protective efficacy of a multi-antigenic adenovirus-based vaccine candidate against Mycobacterium tuberculosis. Front Microbiol. https:\/\/doi.org\/10.3389\/fmicb.2025.1492268","journal-title":"Front Microbiol"},{"key":"4983_CR81","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1097\/CM9.0000000000001858","volume":"135","author":"L Zhang","year":"2022","unstructured":"Zhang L, Ma H, Wan S, Zhang Y, Gao M, Liu X (2022) Mycobacterium tuberculosis latency-associated antigen Rv1733c SLP improves the accuracy of differential diagnosis of active tuberculosis and latent tuberculosis infection. Chin Med J 135:63\u201369. https:\/\/doi.org\/10.1097\/CM9.0000000000001858","journal-title":"Chin Med J"},{"key":"4983_CR80","doi-asserted-by":"publisher","first-page":"292","DOI":"10.1111\/sji.12160","volume":"79","author":"W Zhang","year":"2014","unstructured":"Zhang W, Jiang H, Bai YI, Kang J, Xu ZK, Wang LM (2014) Construction and Immunogenicity of the DNA Vaccine of Mycobacterium Tuberculosis Dormancy Antigen Rv1733c. Scand J Immunol 79:292\u2013298. https:\/\/doi.org\/10.1111\/sji.12160","journal-title":"Scand J Immunol"},{"key":"4983_CR82","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1021\/acschembio.8b00849","volume":"15","author":"H Zheng","year":"2020","unstructured":"Zheng H, Williams JT, Aleiwi B, Ellsworth E, Abramovitch RB (2020) Inhibiting Mycobacterium tuberculosis DosRST signaling by targeting response regulator DNA binding and sensor kinase heme. ACS Chem Biol 15:52\u201362. https:\/\/doi.org\/10.1021\/acschembio.8b00849","journal-title":"ACS Chem Biol"},{"key":"4983_CR83","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1755-8794-1-18","volume":"1","author":"A Zvi","year":"2008","unstructured":"Zvi A, Ariel N, Fulkerson J, Sadoff JC, Shafferman A (2008) Whole genome identification of Mycobacterium tuberculosisvaccine candidates by comprehensive data mining and bioinformatic analyses. BMC Med Genomics 1:1\u201325. https:\/\/doi.org\/10.1186\/1755-8794-1-18","journal-title":"BMC Med Genomics"}],"container-title":["Archives of Microbiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00203-026-04983-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00203-026-04983-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00203-026-04983-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T08:06:34Z","timestamp":1785571594000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00203-026-04983-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,4]]},"references-count":82,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2026,8]]}},"alternative-id":["4983"],"URL":"https:\/\/doi.org\/10.1007\/s00203-026-04983-7","relation":{},"ISSN":["0302-8933","1432-072X"],"issn-type":[{"value":"0302-8933","type":"print"},{"value":"1432-072X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,4]]},"assertion":[{"value":"31 March 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 May 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 May 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 June 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Conflict of interest","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"419"}}